JF
NAGE

Jump Financial’s Niagen Bioscience NAGE Stock Holding History

Jump Financial’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-238,600
Closed -$3.44M – 2324
2025
Q2 		$3.44M Buy
238,600
+142,170
+147% +$1.4M 0.04% 541
2025
Q1 		$665K Sell
96,430
-1,912
-2% -$12K 0.01% 970
2024
Q4 		$522K Buy
+98,342
New +$538K 0.01% 1051
2024
Q3 		– Sell
-25,499
Closed -$69.6K – 2208
2024
Q2 		$69.6K Buy
+25,499
New +$85.3K ﹤0.01% 1666
2022
Q3 		– Sell
-18,000
Closed -$30K – 2052
2022
Q2 		$30K Sell
18,000
-47,700
-73% -$93.3K ﹤0.01% 1527
2022
Q1 		$162K Buy
65,700
+26,800
+69% +$73.2K 0.01% 1350
2021
Q4 		$145K Sell
38,900
-5,092
-12% -$27.5K 0.01% 1168
2021
Q3 		$275K Buy
43,992
+4,392
+11% +$36.2K 0.02% 704
2021
Q2 		$390K Buy
39,600
+16,000
+68% +$140K 0.04% 562
2021
Q1 		$220K Buy
+23,600
New +$187K 0.02% 732

Other funds holding NAGE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jump Financial's NAGE Position: Q3 2025 in Review

Jump Financial sold out of Niagen Bioscience (NAGE) in Q3 2025, closing a stake of 238,600 shares — an estimated $3.44M sold.

Jump Financial first reported a position in NAGE in Q1 2021 and held it in 10 quarters. The position peaked at $3.44M in Q2 2025. 162 funds tracked by Wall St. Rank hold NAGE as of Q3 2025.

  • Jump Financial reported no remaining Niagen Bioscience position as of Q3 2025 after selling out during the quarter.
  • Jump Financial sold 238,600 Niagen Bioscience shares in Q3 2025, an estimated $3.44M.
  • Jump Financial first reported a position in Niagen Bioscience in Q1 2021 and held it in 10 quarters.
  • Jump Financial's Niagen Bioscience position peaked at $3.44M in Q2 2025.
  • 162 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2025.

Based on Jump Financial's 13F filing for Q3 2025, filed 13 Nov 2025.